Wednesday, July 29, 2015
Sprint Bioscience AB Signs agreement with Bayer HealthCare.
May receive up to about 190 million euros ($210.27 million) in potential pre-clinical, clinical and sales-based milestone payments, including initial upfront payment from Bayer on signing agreement.
reuters.com
